Cargando…

Metabolomics: From liver chiromancy to personalized precision medicine in advanced chronic liver disease

Currently there is a lack of accurate biomarkers for diagnosis and prognosis in advanced liver diseases. Either the occurrence of first decompensation, or diagnosis of acute on chronic liver failure, severe alcoholic hepatitis, or hepatocellular carcinoma (HCC), none of the available biomarkers are...

Descripción completa

Detalles Bibliográficos
Autores principales: Procopet, Bogdan, Fischer, Petra, Farcau, Oana, Stefanescu, Horia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871857/
https://www.ncbi.nlm.nih.gov/pubmed/29599900
http://dx.doi.org/10.4254/wjh.v10.i3.371